Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Cash from Investing Activities

Arcus Biosciences Inc Cash from Investing Activities Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Cash from Investing Activities from 2017 to 2018.
  • Arcus Biosciences Inc Cash from Investing Activities for the quarter ending December 12, 2018 was $3m a 756.75% increase of 19m year over year
  • Arcus Biosciences Inc Cash from Investing Activities for the last 12 months ending December 12, 2018 was $-113m a 56.74% decrease of -64m year over year
  • Arcus Biosciences Inc Annual Cash from Investing Activities for 2018 was $-113m a 56.74% decrease of -64m from 2017
  • Arcus Biosciences Inc Annual Cash from Investing Activities for 2017 was $-49m a 20.81% decrease of -10m from 2016
  • Arcus Biosciences Inc Annual Cash from Investing Activities for 2016 was $-39m
Other Cash Flow Metrics:
  • Arcus Biosciences Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -86.39% increase of 6m year over year
  • Arcus Biosciences Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-5m
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Cash from Investing Activities Data

12/2018$3m
09/2018$-83m
06/2018$-16m
03/2018$-16m
12/2017$-42m
09/2017$13m
06/2017$-3m
03/2017$-16m

Annual RCUS Cash from Investing Activities Data

2018$-113m
2017$-49m
2016$-39m